| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $2.8M | +3.3% | +8.7% |
| SG&A Expense | $1.9M | -16.9% | +5.4% |
| Operating Income | -$4.8M | +6.0% | -7.3% |
| Pre-tax Income | -$4.7M | +16.5% | -5.8% |
| Income Tax | $549K | +289.0% | +4896.3% |
| Net Income | -$5.3M | +9.0% | -17.8% |
| EPS (Basic) | -$0.15 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $8.8M | +31.6% | -26.9% |
| Current Assets | $10.5M | +13.0% | -23.5% |
| Total Assets | $11.0M | +11.6% | -23.6% |
| Current Liabilities | $4.2M | -19.8% | -9.2% |
| Long-term Debt | $424K | -6.0% | -14.2% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$13.8M | — | — |
| Investing Cash Flow | $5.0M | — | — |
| Financing Cash Flow | $11.9M | — | — |
| +21.1% |
| +11.8% |
| EPS (Diluted) | -$0.15 | +21.1% | +11.8% |
| $5.1M |
| -17.5% |
| -7.2% |
| Stockholders' Equity | $5.9M | +59.9% | -33.7% |